XOMAP Company Profile and Key Details

Q: Who are the executives of XOMAP?

Mr. Brad SitkoChief Investment OfficerMr. Thomas M. BurnsSenior Vice President of Fin. & Chief Financial OfficerMr. Owen P. Hughes Jr.Executive Chairman & Interim Chief Executive OfficerMr. James R. Neal M.B.A., M.S.Chief Executive Officer & Chairman

NASDAQ : XOMAP

XOMA Royalty

$24.98

0.0111+0.04%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

XOMA Royalty Corporation (XOMAP) stock surged +0.04%, trading at $24.98 on NASDAQ, up from the previous close of $24.97. The stock opened at $24.99, fluctuating between $24.98 and $24.99 in the recent session.

Stock Snapshot

24.97

Prev. Close

301.36M

Market Cap

24.98

Day Low

13.72

P/E Ratio

1.8207

EPS (TTM)

-2.86

Cash Flow per Share

24.99

Open

12.06M

Number of Shares

24.985

Day High

98.43%

Free Float in %

7.73

Book Value

423

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 09, 2026	24.99	24.99	24.98	24.98	423
Jul 08, 2026	24.98	24.98	24.97	24.97	4.72K
Jul 07, 2026	24.95	24.97	24.95	24.97	4.94K
Jul 06, 2026	24.93	24.96	24.93	24.96	3.08K
Jul 02, 2026	24.99	25.00	24.93	24.97	1.7K
Jul 01, 2026	25.50	25.51	25.47	25.51	1.66K
Jun 30, 2026	25.47	25.49	25.47	25.47	10.22K
Jun 29, 2026	25.47	25.47	25.47	25.47	202
Jun 26, 2026	25.45	25.49	25.44	25.49	4.73K
Jun 25, 2026	25.49	25.49	25.46	25.46	839
Jun 24, 2026	25.46	25.48	25.46	25.48	5.42K
Jun 23, 2026	25.44	25.48	25.44	25.48	2.08K
Jun 22, 2026	25.44	25.50	25.42	25.49	7.03K
Jun 18, 2026	25.43	25.45	25.43	25.44	2.38K
Jun 17, 2026	25.43	25.43	25.42	25.42	1.11K
Jun 16, 2026	25.45	25.45	25.40	25.40	5.86K
Jun 15, 2026	25.45	25.45	25.41	25.43	1.44K
Jun 12, 2026	25.51	25.51	25.41	25.47	1K
Jun 11, 2026	25.51	25.51	25.51	25.51	395
Jun 10, 2026	25.51	25.51	25.42	25.42	1.64K

Contact Details

Emeryville, CA 94608

United States

https://www.xoma.com 510 204 7200

About Company

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Stock Peers

KNSA

0.62+0.96%

Kiniksa Pharmaceuticals International, plc$65.38 RPRX

-0.41-0.70%

Royalty Pharma plc$57.96 AVLN

-0.02000038-0.07%

Avalyn Pharma Inc. Common Stock$28.92 HROWM

-0.02-0.08%

Harrow Health, Inc. 11.875% Senior Notes due 2027$26.03 HROWL

0.0478+0.19%

Harrow Health, Inc. 8.625% Senior Notes due 2026$25.61 LFMDP

0.1083+0.47%

LifeMD, Inc.$23.28 GLTO

-0.75-3.36%

Galecto, Inc.$21.58 CGEM

-0.05-0.27%

Cullinan Therapeutics, Inc.$18.38 WBA

0.06+0.50%

Walgreens Boots Alliance, Inc.$11.98 MSLE

0.46+5.12%

Satellos Bioscience Inc.$9.44

Company Overview

XOMA Royalty Corporation (NASDAQ:XOMAP) closed at $24.98 USD, gaining $0.01 (0.04%) from the previous close of $24.97. The stock is currently trading near its 52-week low $24.93 and $30.00. With a market capitalization of about $301.36 million, XOMA Royalty Corporation is classified as a small-cap and shows market-like volatility (beta ~0.86). Key stats such as the average daily volume over the past year has been around 2.90 thousand shares, volume is running light vs its 52-week average. Headquartered in Emeryville, CA, XOMA Royalty Corporation operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Owen Patrick Hughes, the company employs approximately 14 people and listed since December 16, 2020. XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia.

Technical Performance

Average 10-day trading volume of 3.37 thousand shares is slightly above the 3-month average of 2.91 thousand, indicating heightened recent market interest.

Frequently Asked Questions

What is the current XOMA Royalty Corporation (XOMAP) stock price?

XOMA Royalty Corporation (NASDAQ: XOMAP) stock price is $24.98 in the last trading session. During the trading session, XOMAP stock reached the peak price of $24.99 while $24.98 was the lowest point it dropped to. The percentage change in XOMAP stock occurred in the recent session was 0.04% while the dollar amount for the price change in XOMAP stock was $0.01.

XOMAP's industry and sector of operation?

The NASDAQ listed XOMAP is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector. XOMA Royalty Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of XOMAP?

Mr. Brad Sitko
Chief Investment Officer
Mr. Thomas M. Burns
Senior Vice President of Fin. & Chief Financial Officer
Mr. Owen P. Hughes Jr.
Executive Chairman & Interim Chief Executive Officer
Mr. James R. Neal M.B.A., M.S.
Chief Executive Officer & Chairman

How XOMAP did perform over past 52-week?

XOMAP's closing price is 0.2% higher than its 52-week low of $24.93 where as its distance from 52-week high of $30.00 is -16.73%.

How many employees does XOMAP have?

Number of XOMAP employees currently stands at 14.

Link for XOMAP official website?

Official Website of XOMAP is: https://www.xoma.com

How do I contact XOMAP?

XOMAP could be contacted at phone 510 204 7200 and can also be accessed through its website. XOMAP operates from 2200 Powell Street, Emeryville, CA 94608, United States.

How many shares of XOMAP are traded daily?

XOMAP stock volume for the day was 423 shares. The average number of XOMAP shares traded daily for last 3 months was 2.9K.

What is the market cap of XOMAP currently?

The market value of XOMAP currently stands at $301.36M with its latest stock price at $24.98 and 12.06M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Stock Snapshot

24.97

Prev. Close

301.36M

Market Cap

24.98

Day Low

13.72

P/E Ratio

1.8207

EPS (TTM)

-2.86

Cash Flow per Share

24.99

Open

12.06M

Number of Shares

24.985

Day High

98.43%

Free Float in %

7.73

Book Value

423

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 09, 2026	24.99	24.99	24.98	24.98	423
Jul 08, 2026	24.98	24.98	24.97	24.97	4.72K
Jul 07, 2026	24.95	24.97	24.95	24.97	4.94K
Jul 06, 2026	24.93	24.96	24.93	24.96	3.08K
Jul 02, 2026	24.99	25.00	24.93	24.97	1.7K
Jul 01, 2026	25.50	25.51	25.47	25.51	1.66K
Jun 30, 2026	25.47	25.49	25.47	25.47	10.22K
Jun 29, 2026	25.47	25.47	25.47	25.47	202
Jun 26, 2026	25.45	25.49	25.44	25.49	4.73K
Jun 25, 2026	25.49	25.49	25.46	25.46	839
Jun 24, 2026	25.46	25.48	25.46	25.48	5.42K
Jun 23, 2026	25.44	25.48	25.44	25.48	2.08K
Jun 22, 2026	25.44	25.50	25.42	25.49	7.03K
Jun 18, 2026	25.43	25.45	25.43	25.44	2.38K
Jun 17, 2026	25.43	25.43	25.42	25.42	1.11K
Jun 16, 2026	25.45	25.45	25.40	25.40	5.86K
Jun 15, 2026	25.45	25.45	25.41	25.43	1.44K
Jun 12, 2026	25.51	25.51	25.41	25.47	1K
Jun 11, 2026	25.51	25.51	25.51	25.51	395
Jun 10, 2026	25.51	25.51	25.42	25.42	1.64K

Contact Details

Emeryville, CA 94608

United States

https://www.xoma.com 510 204 7200

About Company

Stock Peers

KNSA

0.62+0.96%

Kiniksa Pharmaceuticals International, plc$65.38 RPRX

-0.41-0.70%

Royalty Pharma plc$57.96 AVLN

-0.02000038-0.07%

Avalyn Pharma Inc. Common Stock$28.92 HROWM

-0.02-0.08%

Harrow Health, Inc. 11.875% Senior Notes due 2027$26.03 HROWL

0.0478+0.19%

Harrow Health, Inc. 8.625% Senior Notes due 2026$25.61 LFMDP

0.1083+0.47%

LifeMD, Inc.$23.28 GLTO

-0.75-3.36%

Galecto, Inc.$21.58 CGEM

-0.05-0.27%

Cullinan Therapeutics, Inc.$18.38 WBA

0.06+0.50%

Walgreens Boots Alliance, Inc.$11.98 MSLE

0.46+5.12%

Satellos Bioscience Inc.$9.44

Company Overview

Technical Performance

Average 10-day trading volume of 3.37 thousand shares is slightly above the 3-month average of 2.91 thousand, indicating heightened recent market interest.

Valuation Metrics

XOMA Royalty Corporation trades at a P/E ratio of 15.14, slightly below the S&P 500 average, with a price-to-sales ratio of 10.99 and a price-to-book ratio of 2.63 suggesting the stock is closer to book value. The P/FCF stands at 45.43, also above market averages.

Dividend & Fair Value

XOMA Royalty Corporation last paid a dividend of 2.16 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$2.04. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

XOMA Royalty Corporation earnings surprise history is a mixed track record. The quarter that ended May 13, 2026, missed forecasts by 7.33%. The prior quarter beat by 7.33%. Over the last six quarters, Apple has recorded several small beats. These include -34600.0% in August 13, 2025.

Financial & Profitability Overview

Over the trailing twelve months, XOMA Royalty generated $4.76M in revenue, or $0.41 per share. Gross margin was 81.08%, operating margin -460.03%, and net profit margin -858.15%. Returns are negative, with ROA at -17.43% and ROE at -46.02%.
On valuation metrics, XOMA Royalty trades at a P/E of 15.14, P/S of 10.99 and P/B of 2.63. The current ratio is 3.59 and quick ratio is 3.59. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -521.69 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 1.10, supported by a cash flow-to-debt ratio of 0.05.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, XOMA Royalty posted revenue of $4.76M, down slightly from $6.03M in the prior quarter. Gross profit was $3.86M (margin 81.08%). Operating income was - $21.89M (margin -460.0%). Net income was- $40.83M (EPS - $3.56).
The company ended the quarter with $153.61M in cash and short-term investments, a total debt of $124.45M, and net debt of - $29.00M. Total assets were $234.30M, with equity of $88.72M. Financials further reflected weakness, with operating cash flow of - $18.16M, free cash flow of - $32.83M, and capital expenditures of - $14.67M.

Price Forecast & Outlook

Our AI price prediction model suggests that XOMA Royalty Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -12.37%, with price expected at $21.89 by November 24, 2023, within a range of $21.51 to $22.26

Key Takeaways

XOMA Royalty Corporation (NASDAQ:XOMAP) shares are flat -4.06% year-to-date Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows XOMA Royalty Corporation trading at a premium to the broader market with a P/E of 15.14.

Frequently Asked Questions

What is the current XOMA Royalty Corporation (XOMAP) stock price?

XOMAP's industry and sector of operation?

Who are the executives of XOMAP?

How XOMAP did perform over past 52-week?

XOMAP's closing price is 0.2% higher than its 52-week low of $24.93 where as its distance from 52-week high of $30.00 is -16.73%.

How many employees does XOMAP have?

Number of XOMAP employees currently stands at 14.

Link for XOMAP official website?

Official Website of XOMAP is: https://www.xoma.com

How do I contact XOMAP?

XOMAP could be contacted at phone 510 204 7200 and can also be accessed through its website. XOMAP operates from 2200 Powell Street, Emeryville, CA 94608, United States.

How many shares of XOMAP are traded daily?

XOMAP stock volume for the day was 423 shares. The average number of XOMAP shares traded daily for last 3 months was 2.9K.

What is the market cap of XOMAP currently?

The market value of XOMAP currently stands at $301.36M with its latest stock price at $24.98 and 12.06M of its shares outstanding.

Employees	14
Beta	0.87
Sales or Revenue	$4.76M
5Y Sales Change%	-0.345%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Pharmaceuticals

Employees	14
Beta	0.87
Sales or Revenue	$4.76M
5Y Sales Change%	-0.345%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Pharmaceuticals

XOMAP Company Profile and Key Details

XOMA Royalty

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Price Forecast & Outlook

Key Takeaways

Financial & Profitability Overview

Quarterly Financial Highlights